Selected article for: "acute ards respiratory distress syndrome and lung function"
Author: Soto, Maira; diZerega, Gere; Rodgers, Kathleen E
Title: Countermeasure and therapeutic: A(1–7) to treat acute respiratory distress syndrome due to COVID-19 infection
  • Cord-id: m193hruc
  • Document date: 2020_11_10
    • ID: m193hruc
    Snippet: In the wake of the COVID-19 pandemic it has become clear that there is a need for therapies that are capable of reducing damage caused to patients from infections. Infections that induce Acute Respiratory Distress Syndrome (ARDS) are especially devastating because lung damage is so critical and difficult to manage. Angiotensin (1–7) [A(1–7)] has already been shown to protect pulmonary health and architecture in various models of disease. There is also evidence that A(1–7) can modulate immu
    Document: In the wake of the COVID-19 pandemic it has become clear that there is a need for therapies that are capable of reducing damage caused to patients from infections. Infections that induce Acute Respiratory Distress Syndrome (ARDS) are especially devastating because lung damage is so critical and difficult to manage. Angiotensin (1–7) [A(1–7)] has already been shown to protect pulmonary health and architecture in various models of disease. There is also evidence that A(1–7) can modulate immune function and protect various organs (lung, kidney, and heart) from oxidative damage and inflammation. Here we focus on making a case for the development of novel therapies that target the protective arm of the Renin Angiotensin System (RAS).

    Search related documents:
    Co phrase search for related documents
    • acid aspiration and lung dry wet weight ratio: 1
    • acid aspiration and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acid instillation and lung congestion: 1
    • acid instillation and lung disease: 1
    • acid instillation and lung edema: 1
    • acid instillation and lung injury: 1, 2, 3, 4, 5, 6, 7
    • admission time and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • admission time and lung edema: 1
    • admission time and lung health: 1
    • admission time and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10